Literature DB >> 1382852

Age-related immunoreactivity pattern in medulloblastoma.

S Patt1, C Zimmer.   

Abstract

Thirty-five paraffin-embedded medulloblastomas (19 from children and 16 from adults; 24 classic medulloblastomas, 10 desmoplastic medulloblastomas, 1 tumor with neuronal differentiation) were examined for reactions with antibodies against glial fibrillary acidic protein (GFAP), cytokeratins KL1 and MNF116, desmin, and vimentin. Only the tumor from the youngest patient, a 152-day-old boy, showed a positive immunoreaction for cytokeratins. Because of this age-related expression of cytokeratins in medulloblastomas primarily in very young children, cytokeratin positivity was interpreted as a sign of tumor immaturity. Five medulloblastomas showed scattered GFAP-positive reactive astrocytes and/or other positive, probably neoplastic, cells. Only two tumors showed GFAP immunoreactivity in unequivocally neoplastic cells. Of six tumors that reacted with vimentin, three showed strong reactivity throughout, one being the tumor from the 152-day-old boy. The remaining three demonstrated nests of vimentin-positive cells with weak or intense somatic immunoreactivity for vimentin. None of the 35 cases showed positivity for desmin; indicating that mesenchymal differentiation is restricted to the rare so-called medullomyoblastomas.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1382852     DOI: 10.1007/bf00296563

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  30 in total

1.  Immunohistochemistry of primitive neuroectodermal tumors in infants with special emphasis on cytokeratin expression.

Authors:  T Grieshammer; C Zimmer; K T Vogeley
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

2.  Cytokeratin expression in a congenital multipotential primitive neuroectodermal tumor.

Authors:  C Zimmer; J Figols; S Patt; J Cervos-Navarro
Journal:  Childs Nerv Syst       Date:  1991-11       Impact factor: 1.475

3.  Differentiation in medulloblastomas and other primitive neuroectodermal tumours.

Authors:  P J Sime; A Gordon; M L Hooper; J E Bell
Journal:  Br J Neurosurg       Date:  1989       Impact factor: 1.596

4.  The distribution of laminin in human brain tumors: an immunohistochemical study.

Authors:  M T Giordana; I Germano; G Giaccone; A Mauro; A Migheli; D Schiffer
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

5.  The ultrastructure of medulloblastomas.

Authors:  F Matakas; J Cervós-Navarro; F Gullotta
Journal:  Acta Neuropathol       Date:  1970       Impact factor: 17.088

6.  Primitive neuroectodermal tumors including the medulloblastoma: glial differentiation signaled by immunoreactivity for GFAP is restricted to the pure desmoplastic medulloblastoma ("arachnoidal sarcoma of the cerebellum").

Authors:  M J Herpers; H Budka
Journal:  Clin Neuropathol       Date:  1985 Jan-Feb       Impact factor: 1.368

7.  Glial fibrillary acidic protein in medulloblastomas and other embryonic CNS tumours of children.

Authors:  E Schindler; F Gullotta
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

8.  Neuron-specific enolase and neurofilament protein as markers of differentiation in medulloblastoma.

Authors:  M E Velasco; M W Ghobrial; E R Ross
Journal:  Surg Neurol       Date:  1985-02

9.  Keratin in epithelioid sarcoma. An immunohistochemical study.

Authors:  D R Chase; F M Enzinger; S W Weiss; J M Langloss
Journal:  Am J Surg Pathol       Date:  1984-06       Impact factor: 6.394

10.  Brain tumors of childhood: nosological and diagnostic problems.

Authors:  D Schiffer; M T Giordana; M C Vigliani
Journal:  Childs Nerv Syst       Date:  1989-08       Impact factor: 1.475

View more
  1 in total

1.  Tumor-Associated Macrophages Correlate With Prognosis in Medulloblastoma.

Authors:  Jin Zhang; Xia Yuan; Yuan Wang; Jingjing Liu; Zhigang Li; Shuting Li; Yan Liu; Xiaojun Gong; Yanling Sun; Wanshui Wu; Liming Sun; Shuxu Du; Tianyou Wang
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.